The largest holder of Elevance Health stock is Vanguard Capital Management LLC, with 14.1 million shares (6.48% of the company), worth about $5.52 billion as of September 25, 2026. The 10 largest holders together own 36.4%.
In Q2 2026, 1,690 institutional holdings reports listed shares worth $78.90 billion.
Insiders reported 59 transactions in the last two years: 9 sales worth $8.47 million and 6 purchases. The newest one on file is from July 17, 2026 (Peru Ramiro G, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through July 17, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Vanguard Capital Management LLC | 14.1 million | 6.48% | $5.5B |
| BlackRock Advisors LLC | 13.6 million | 6.27% | $5.3B |
| State Street Corporation | 10.4 million | 4.81% | $4.1B |
| Wellington Trust Co., NA | 9.2 million | 4.25% | $3.6B |
| Vanguard Portfolio Management LLC | 6.2 million | 2.87% | $2.4B |
| Sanders Capital LLC | 5.8 million | 2.69% | $2.3B |
| Geode Capital Management LLC | 5.2 million | 2.38% | $2.0B |
| BlackRock Life Ltd. | 5.0 million | 2.32% | $2.0B |
| Harris Associates LP | 4.9 million | 2.27% | $1.9B |
| Artisan Partners Holdings LP | 4.6 million | 2.11% | $1.8B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,690 | – | $78.9B |
| Q1 2026 | 1,533 | 195.0 million | $57.0B |
| Q4 2025 | 1,628 | 203.0 million | $71.2B |
| Q3 2025 | 1,603 | 198.0 million | $63.9B |
| Q2 2025 | 1,685 | 207.0 million | $80.2B |
| Q1 2025 | 1,752 | 205.0 million | $89.0B |
| Q4 2024 | 1,693 | 208.0 million | $76.6B |
| Q3 2024 | 1,785 | 211.0 million | $109.0B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Peru Ramiro G | Jul 17, 2026 | Director | Purchase at price 366.05 per share. | $366,050 |
| Boudreaux Gail A Koziara | Jul 17, 2026 | Chief Executive Officer | Purchase at price 366.41 - 368.25 per share. | $1.0M |
| Penczek Ronald W | Jun 12, 2026 | Officer | Sale at price 403.16 per share. | $148,766 |
| Dixon Robert L Jr | Jun 11, 2026 | Director | Sale at price 401.77 per share. | $60,667 |
| Penczek Ronald W | May 19, 2026 | Officer | Sale at price 403.13 per share. | $617,192 |
| Penczek Ronald W | May 19, 2026 | Officer | Conversion of Exercise of derivative security at price 271.27 - 311.48 per share. | $450,579 |
| Strable-Soethout Deanna D | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Schulman Amy W. | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Dixon Robert L Jr | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Devore Susan D | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Neri Antonio F | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Schneider Ryan M. | May 13, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
Newest 12 of 59 insider transactions in the last two years.
Vanguard Capital Management LLC, with 6.48% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.27%) and State Street Corporation (4.81%).
1,690 institutional holdings reports listed Elevance Health shares in Q2 2026 worth $78.90 billion.
In the last two years insiders reported 9 sales and 6 purchases (59 transactions in all); the newest on file is from July 17, 2026.